Advanced Veterinary Protection for the Belgian & European Agricultural Sectors
Belgium has long established itself as a global powerhouse for vaccine manufacturing and research. Known as the "Health Valley" of Europe, the country boasts a dense ecosystem of biotech firms, academic research centers, and world-class logistics infrastructure. For any vaccine products manufacturer, Belgium represents a strategic nexus, offering unparalleled access to the European market and a workforce highly skilled in life sciences.
The industrial landscape in Belgium is characterized by its focus on innovation and high-quality standards (GMP/ISO). From the Flanders region to Wallonia, vaccine factories are equipped with cutting-edge bioreactors and automated inspection lines. Local manufacturers specialize not only in human healthcare but also in veterinary medicine, supporting Belgium's robust livestock and poultry industries. Our collaborative approach aligns with these Belgian standards, ensuring that every product exported or manufactured in partnership meets the rigorous biosecurity requirements of the region.
Driving the future of immunization through AI and advanced biotechnology
Next-Gen Platforms
Cold Chain Mastery
Predictive Modeling
Carbon Logistics
The vaccine industry in Belgium is currently undergoing a massive digital transformation. Manufacturers are increasingly integrating Artificial Intelligence (AI) to optimize yield and predict potential contamination before it occurs. Furthermore, the shift towards personalized medicine and mRNA technology is redefining how factories are built—moving away from massive single-product plants to flexible, modular facilities that can switch between different vaccine types within days.
Sustainability is also a key trend. Leading Belgian factories are now implementing "Green GMP" practices, reducing water usage in sterilization processes and utilizing renewable energy to power the intensive refrigeration units required for storage. This commitment to sustainability ensures that the vaccine supply chain is resilient to both biological and environmental challenges.
In Belgium, localized application scenarios are diverse. For example, in the poultry sector, the prevention of Newcastle Disease and Avian Influenza is critical for maintaining export status. Our inactivated and live vaccines are tailored for large-scale farm applications where biosecurity is the top priority. Additionally, for the bovine industry in the Ardennes region, specialized vaccines against Bovine Viral Diarrhea are essential for herd health and productivity.
Connecting Hangzhou Innovation with Belgian Industrial Excellence
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
When searching for a vaccine products manufacturer in Belgium, quality assurance is the primary differentiator. Belgian facilities are governed by the Federal Agency for Medicines and Health Products (FAMHP), ensuring that every vial produced adheres to the highest safety protocols.
Our partnership network leverages this Belgian expertise to offer:
With the rise of highly pathogenic strains like H5N8, having a factory partner that can rapidly pivot production is vital. Our facilities in Belgium and China are synchronized to provide immediate responses to emerging veterinary threats.
High-efficiency veterinary solutions and specialized production equipment
SJ medical
